These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 24804797)
1. Vaccines against invasive Salmonella disease: current status and future directions. MacLennan CA; Martin LB; Micoli F Hum Vaccin Immunother; 2014; 10(6):1478-93. PubMed ID: 24804797 [TBL] [Abstract][Full Text] [Related]
2. Prospects for prevention of Salmonella infection in children through vaccination. McGregor AC; Waddington CS; Pollard AJ Curr Opin Infect Dis; 2013 Jun; 26(3):254-62. PubMed ID: 23591641 [TBL] [Abstract][Full Text] [Related]
3. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development. Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396 [TBL] [Abstract][Full Text] [Related]
5. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653 [TBL] [Abstract][Full Text] [Related]
6. Vaccine value profile for invasive non-typhoidal Salmonella disease. Martin LB; Tack B; Marchello CS; Sikorski MJ; Owusu-Dabo E; Nyirenda T; Mogasale V; Crump JA Vaccine; 2024 Jul; 42(19S1):S101-S124. PubMed ID: 39003017 [TBL] [Abstract][Full Text] [Related]
7. Live attenuated vaccines for invasive Salmonella infections. Tennant SM; Levine MM Vaccine; 2015 Jun; 33 Suppl 3(0 3):C36-41. PubMed ID: 25902362 [TBL] [Abstract][Full Text] [Related]
8. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease. Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460 [TBL] [Abstract][Full Text] [Related]
9. Nontyphoidal salmonella disease: Current status of vaccine research and development. Tennant SM; MacLennan CA; Simon R; Martin LB; Khan MI Vaccine; 2016 Jun; 34(26):2907-2910. PubMed ID: 27032517 [TBL] [Abstract][Full Text] [Related]
10. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly. Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216 [TBL] [Abstract][Full Text] [Related]
11. Glycoconjugate vaccine strategies for protection against invasive Salmonella infections. Simon R; Levine MM Hum Vaccin Immunother; 2012 Apr; 8(4):494-8. PubMed ID: 22370510 [TBL] [Abstract][Full Text] [Related]
12. Vaccines for typhoid fever and other salmonelloses. Martin LB Curr Opin Infect Dis; 2012 Oct; 25(5):489-99. PubMed ID: 22825288 [TBL] [Abstract][Full Text] [Related]
14. Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed. Fuche FJ; Sow O; Simon R; Tennant SM Clin Vaccine Immunol; 2016 Sep; 23(9):737-45. PubMed ID: 27413069 [TBL] [Abstract][Full Text] [Related]
15. Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa. Baliban SM; Yang M; Ramachandran G; Curtis B; Shridhar S; Laufer RS; Wang JY; Van Druff J; Higginson EE; Hegerle N; Varney KM; Galen JE; Tennant SM; Lees A; MacKerell AD; Levine MM; Simon R PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005493. PubMed ID: 28388624 [TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis. Rossi O; Caboni M; Negrea A; Necchi F; Alfini R; Micoli F; Saul A; MacLennan CA; Rondini S; Gerke C Clin Vaccine Immunol; 2016 Apr; 23(4):304-14. PubMed ID: 26865597 [TBL] [Abstract][Full Text] [Related]
17. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice. Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285 [TBL] [Abstract][Full Text] [Related]
18. Current perspectives on invasive nontyphoidal Salmonella disease. Haselbeck AH; Panzner U; Im J; Baker S; Meyer CG; Marks F Curr Opin Infect Dis; 2017 Oct; 30(5):498-503. PubMed ID: 28731899 [TBL] [Abstract][Full Text] [Related]
19. Vi Capsular Polysaccharide Produced by Recombinant Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685 [TBL] [Abstract][Full Text] [Related]
20. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever. Das S; Chowdhury R; Pal A; Okamoto K; Das S Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]